| 000 | 01595 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513192230.0 | ||
| 264 | 0 | _c19991007 | |
| 008 | 199910s 0 0 spa d | ||
| 022 | _a0036-4355 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCanales Albendea, M A | |
| 245 | 0 | 0 |
_a[Severe esophageal stenosis secondary to the administration of chemotherapy in a patient with acute myeloblastic leukemia]. _h[electronic resource] |
| 260 |
_bSangre _cJun 1999 |
||
| 300 |
_a245-6 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBusulfan _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDilatation |
| 650 | 0 | 4 |
_aEsophageal Stenosis _xetiology |
| 650 | 0 | 4 |
_aEsophagitis _xchemically induced |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelomonocytic, Acute _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
| 650 | 0 | 4 |
_aUlcer _xchemically induced |
| 700 | 1 | _aAlvarez Román, M T | |
| 700 | 1 | _aVillanueva Pavón, R | |
| 700 | 1 | _aHernández Navarro, F | |
| 773 | 0 |
_tSangre _gvol. 44 _gno. 3 _gp. 245-6 |
|
| 999 |
_c10438990 _d10438990 |
||